The federal bet on clinical AI that acts on its own

Federal health officials are making a bold move by investing in AI that can independently make clinical decisions, including diagnosing patients and adjusting medications, a significant leap from AI's traditional role as a supportive tool. This initiative underscores the growing trust in AI's capabilities to enhance patient care efficiency and accuracy. While the implications are vast, there are also concerns about oversight, accountability, and the potential for errors in autonomous systems, making this a pivotal moment for the future of healthcare technology.